Member Info for 86KB

Lordiscup, possibly could be them. If they do mention them then will be go mental. It does say material contract so lets see.

Its about the mcap not the number of shares

I wonder who the firm is they are in discussions with. Just have to look around the area and see who is already there.

I guess we might see 0.045 today before close. lol

Boom, hold going to see a big run here

The Company wishes to clarify that Riversgold and Oracle are in discussions regarding a material contract with a firm to progress operations at the Northern Zone and that any further announcement will be made in due course as appropriate.

Think a could see heading to 0.03s by close and then next week see 0.045-0.05. Depending on news much higher of course. Went to 0.075 on assay results, alot more has been done since then. Mining licence and contract deal lands it goes on a big run. GLA.

I have had similar issues previously with ii wasted a whole day trying to fix the issue.

Worth following this page

https://x.com/CPEC_Official?t=S7XpMJOTLo1q0PfsMGrHKA&s=09

They have been in talks with 2 potential partners and everything thats going right now with both pakistan and china visiting each country for growth I think we will get something very soon for Thar

Reckon we will see fomo going into close. News probably Monday or Tuesday morning as Rgl will start trading again on Tuesday.

Thanks popeye, can't get anything for 90k shares with IG

NT to buy, is it in auction?

Yes we have started to build back up since hitting the lows. Closing above 11.20p will be great.

Can undestand the frustration from longterm holders, but think this is the time finally for the company to turn things around. We know they have recently raised funds so wouldn't think another anytime soon. We could really see a snowball effect here with lots of news due with all the projects.

Vertex & Enlaza:

Vertex announced a deal with Enlaza in September 2025, worth over $2 billion, to create new autoimmune drugs and improve conditioning methods.

AbbVie & Capstan Therapeutics:

AbbVie is acquiring Capstan Therapeutics for up to $2.1 billion, gaining rights to a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases (June 2025).

Roche Genentech & Repertoire Immune:

Genentech partnered with Repertoire Immune in April 2025 to discover and develop T-cell targeted medicines, with Repertoire eligible for up to $765 million in payments and royalties.

Monte Rosa & Novartis:

Monte Rosa received a $150 million upfront agreement from Novartis for its VAV1 antibody, MRT-6160, which targets autoimmune and cancer indications (2024).

Anyone remember the black cat syndicate deal? Naheed mentioned a few times they would be looking at something similar. There were some articles also comparing to saturn on asx awhile ago.

Remember Naheed was also appointed as a member for the national hydrogen working group too.

Yes it is just a waiting game as non of us know when news will land. Its could be a lot sooner than some think. It will test ones patience for sure, but if you have done your research then you will be confident in your holding and be rewarded in the end. Boredom can get to some thats why I say if you have spare funds then can trade others whilst waiting for news here.

Well off you go roger, seems like you've been become a grumpy old man whilst waiting for news.